Search results
Results From The WOW.Com Content Network
Pharmacology can be applied within clinical sciences. Clinical pharmacology is the application of pharmacological methods and principles in the study of drugs in humans. [21] An example of this is posology, which is the study of dosage of medicines. [22] Pharmacology is closely related to toxicology.
Beta blockers exert their pharmacological effect, decreased heart rate, by binding to and competitively antagonising a type of receptor called beta adrenoceptors. [1]In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect. [2]
Most plasma substances have primarily their free concentrations regulated, which thus remains the same, so extensive protein binding increases total plasma concentration (free + protein-bound). This decreases clearance compared to what would have been the case if the substance did not bind to protein. [ 9 ]
With worldwide research into pharmacology as well as medicine, traditional medicines or ancient herbal medicines are often translated into modern remedies, such as the anti-malarial group of drugs called artemisinin isolated from Artemisia annua herb, a herb that was known in Chinese medicine to treat fever.
The European Journal of Pharmacology is a peer-reviewed scientific journal in the field of pharmacology. It publishes full-length papers on the mechanisms of action of chemical substances affecting biological systems, and short reviews debating recent advances in rapidly developing fields within its scope. Papers are presented under these headings:
Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage).
Dextromethorphan, sold under the brand name Robitussin among others, is a cough suppressant used in many cough and cold medicines. [6] In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in people with major depressive disorder.
GAD is a common disorder in which the central feature is excessively worrying about numerous events. Key symptoms include excessive anxiety about events and issues going on around them and difficulty controlling worrisome thoughts that persists for at least 6 months. Antidepressants provide a modest to moderate reduction in anxiety in GAD. [46]